Condition

Arthralgia

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 31 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials31
Recruiting0
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

31 shown
Multicomponent Care for Aromatase Inhibitor-Related Musculoskeletal SymptomsNCT07409948 · 2026-03-15
NOT_YET_RECRUITING
Effect of a Specific Hand Intervention in Women With Arthralgia Secondary to Hormone Therapy Following Breast Cancer.NCT06746376 · 2025-04-01
NOT_YET_RECRUITING
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated ArthralgiaNCT05703178 · 2023-01-19
ACTIVE_NOT_RECRUITING
Pilot Observational Study Examining the Effect of Endocrine Therapy on AgingNCT05700006 · 2022-07-25
COMPLETED
The Effect of Walking Exercise Based on TOUS on Peripheral Neuropathy and Arthralgia-Myalgia in Women With Breast CancerNCT05448209 · 2022-07-20
COMPLETED
Effect of Acupuncture vs Chinese Medicine vs Combined Therapy on Aromatase Inhibitor-related Arthralgia Among Women With Early-Stage Breast CancerNCT05264649 · 2022-05-05
UNKNOWN
Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated ArthralgiasNCT04754399 · 2021-04-16
COMPLETED
Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase InhibitorsNCT03953157 · 2019-10-07
COMPLETED
Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated ArthralgiasNCT03384095 · 2018-12-14
WITHDRAWN
Opera® for Aromatase Inhibitor-related Arthralgia Management (AIA)NCT04161833 · 2018-11-01
COMPLETED
Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant ChemotherapyNCT03566394 · 2018-07-02
UNKNOWN
Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast CancerNCT02831582 · 2016-10-12
COMPLETED
Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile ApplicationNCT02758990 · 2016-03-01
TERMINATED
ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus InfectionNCT02075593 · 2014-12-17
COMPLETED
Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast CancerNCT01612728 · 2013-10-01
WITHDRAWN
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor TreatmentNCT01573442 · 2013-09-10
COMPLETED
Survivin as Predictive Biomarker for RANCT03444623 · 2013-06-01
UNKNOWN
S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone ThpyNCT01385137 · 2012-02-01
COMPLETED
The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast CancerNCT01351844 · 2011-05-01
TERMINATED
Exercise Intervention in Breast Cancer Patients With Treatment-Induced ArthralgiaNCT01236417 · 2010-03-01
COMPLETED
Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal SymptomsNCT02118636 · 2009-10-01
COMPLETED
Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast CancerNCT01896050 · 2009-09-01
COMPLETED
Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer PatientsNCT01814397 · 2009-07-01
COMPLETED
Hormones and Physical Exercise (HOPE) StudyNCT02056067 · 2009-06-01
COMPLETED
Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase InhibitorsNCT00954564 · 2009-06-01
COMPLETED
A Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors and TamoxifenNCT01223833 · 2009-04-01
COMPLETED
CYP19 Genetic Polymorphism & Aromatase Inhibitor(AI)NCT00973505 · 2009-03-01
UNKNOWN
Breast Cancer Tumor Care Observational ProgrammeNCT00660244 · 2008-02-01
COMPLETED
Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-EffectsNCT00497458 · 2007-07-01
UNKNOWN
Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast CancerNCT00416715 · 2006-10-01
COMPLETED
Changes in Knee Articular Cartilage Volume in Women on Aromatase InhibitorsNCT00111241 · 2005-05-01
COMPLETED

Common interventions

PlaceboOTHER4anastrozoleDRUG2assessment of therapy complicationsPROCEDURE2letrozoleDRUG2omega-3 fatty acidDIETARY_SUPPLEMENT2questionnaire administrationOTHER2TestosteroneDRUG2acupunctureDEVICE1anastrozole, letrozole, exemestaneDRUG1aromatase inhibition therapy - OBSERVATIONAL ONLYOTHER1Aromatase inhibitorDRUG1Aromatase Inhibitor(Femara or Arimidex)DRUG1aromatase inhibitors (letrozole, anastrozole)DRUG1Attention Control (Health Education)BEHAVIORAL1Axon EyewearDEVICE1BroccoliOTHER1CaffeineDIETARY_SUPPLEMENT1calcium carbonateDIETARY_SUPPLEMENT1calcium citrateDIETARY_SUPPLEMENT1calcium glucarateDIETARY_SUPPLEMENT1calcium gluconateDRUG1Cannabidiol (CBD)DRUG1ChocolateOTHER1cholecalciferolDIETARY_SUPPLEMENT1CoffeeOTHER1

Trial status mix

COMPLETED19
UNKNOWN5
NOT_YET_RECRUITING2
TERMINATED2
WITHDRAWN2
ACTIVE_NOT_RECRUITING1

Phase mix

NA11
PHASE26
PHASE35
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.